|
A comparative study of the prognosis in end-stage diabetic kidney disease patients treated with hemodialysis and those treated with peritoneal dialysis
2013, 12 (05):
238-342.
doi: 10.3969/j.issn.1671-4091.2013.05.00
[Abstract] Objectives To investigate the clinical outcome and survival rate of diabetic end stage renal disease (ESRD) patients treated with continuous ambulatory peritoneal dialysis (CAPD) or maintenance hemodialysis (HD). Methods Our retrospective study collected datas included 115 dialysis patients secondary to diabetic nephropathy (73 on HD, 42 on CAPD) treated in Xinhua hospital during the period between January 2007 and May 2012. Patients on dialysis for less than 3 months were excluded. We compared the clinical parameters, complications, survival rate, mortality and its causes between HD and CAPD groups before and after dialysis. Results There were no significant differences in the baseline characteristics between the two groups of pre-dialysis patients, such as age when first dialysis, serum creatinine, blood urea nitrogen, glomerular filtration rate, hemoglobin, serum albumin, uric acid (P>0.05). There were no significant differences in the level of hemoglobin, serum calcium, phosphorus and iPTH between the two groups at the end time of observation (P>0.05), while the level of Serum albumin were significantly higher in HD group compared with CAPD group (P<0.05). The level of serum albumin was significantly increased in HD group at the end time of observation(P<0.05). The incidence of cardiac insufficiency, bleeding events, cerebral infarction were higher in HD patients than in CAPD patients (P<0.05), while the incidence of infection was similar(P>0.05). There were no significant differences on mortality rate between the two groups (P> 0.05). The main causes of death in two groups were heart failure, severe infections, bleeding and cerebrovascular disease. There were no statistically significant differences in the causes of death constitution (P>0.05). 1-, 3-,5-year survival rate in CAPD group were significant higher than HD group (P<0.05). When performed subgroup analysis, 1-, 3-,5-, 7-year survival rate of CAPD patients with age≥65 years were significant lower compared with HD patients (P<0.05). Conclusion In this study, CAPD has demonstrated 5 year-survival advantages over HD in the younger diabetic ESRD patients (less than 65 years old). HD elderly patients (above 65 years old) have better survival than CAPD patients, then HD may be a better dialysis modality for elderly diabetic ESRD patients.
Metrics
|